Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
All content for Digital Pathology Podcast is the property of Aleksandra Zuraw, DVM, PhD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
171: Real-World Digital Readiness: Turning Stains into Reliable Scans
Digital Pathology Podcast
22 minutes
1 week ago
171: Real-World Digital Readiness: Turning Stains into Reliable Scans
Send us a text Is your lab truly digitally ready—or just scanning slides? That’s the question I unpack in this live discussion from Day 2 of SITC’s 40th Anniversary Meeting, joined by David Anderson (Biocare Medical) and Don Ariyakumar (Hamamatsu Photonics). Together, we explore what digital readiness really means for multiplex immunofluorescence (mIF) and how to build reliable, reproducible workflows that scale from research to clinical settings. What We Discuss The Discovery Funnel I...
Digital Pathology Podcast
Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
